Compare Oswal Overseas with Similar Stocks
Dashboard
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -28.88% and Operating profit at 7.06% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at 10.79 times
- The company has been able to generate a Return on Capital Employed (avg) of 4.23% signifying low profitability per unit of total capital (equity and debt)
Flat results in Dec 25
Risky - Negative EBITDA
Stock DNA
Sugar
INR 163 Cr (Micro Cap)
NA (Loss Making)
19
0.00%
-4.98
175.42%
-34.20
Total Returns (Price + Dividend) 
Oswal Overseas for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Oswal Overseas Ltd Upgraded to Sell on Technical Improvements Despite Fundamental Challenges
Oswal Overseas Ltd, a micro-cap player in the sugar sector, has seen its investment rating upgraded from Strong Sell to Sell as of 23 March 2026. This change is primarily driven by a shift in technical indicators, even as the company continues to grapple with weak financial fundamentals and valuation concerns. The stock’s recent performance and underlying metrics present a mixed picture for investors seeking clarity in a volatile market.
Read full news article
Oswal Overseas Ltd Downgraded to Strong Sell Amid Mixed Technicals and Weak Fundamentals
Oswal Overseas Ltd, a player in the sugar industry, has seen its investment rating downgraded from Sell to Strong Sell as of 9 March 2026. This adjustment reflects a complex interplay of deteriorating fundamental metrics, challenging valuation dynamics, and mixed technical signals, despite the company’s impressive long-term stock returns. Investors are advised to carefully consider these factors amid the company’s ongoing financial struggles and volatile market behaviour.
Read full news article
Oswal Overseas Ltd is Rated Sell
Oswal Overseas Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 February 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
16-Feb-2026 | Source : BSENewspaper publication for the unaudited financial results for the quarter ended on December 31 2025 is attached herewith.
Financial Results For The Quarter And Nine Months Ended On December 31 2025
14-Feb-2026 | Source : BSEFinancial Results with Limited Review Report Attached herewith
Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended On December 31 2025
14-Feb-2026 | Source : BSEOutcome Attached herewith
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Surjeet Singh Huf (18.91%)
None
17.01%
Quarterly Results Snapshot (Standalone) - Dec'25 - YoY
YoY Growth in quarter ended Dec 2025 is -91.71% vs -77.11% in Dec 2024
YoY Growth in quarter ended Dec 2025 is 58.44% vs -277.69% in Dec 2024
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -97.53% vs -52.65% in Sep 2024
Growth in half year ended Sep 2025 is 22.44% vs 50.65% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -95.40% vs -65.95% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 38.62% vs -15.90% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -55.53% vs -27.64% in Mar 2024
YoY Growth in year ended Mar 2025 is -127.16% vs -826.67% in Mar 2024






